Caffeine Market By TYPE (SYNTHESIZED CAFFEINE, NATURAL CAFFEINE), By APPLICATION (FOOD, BEVERAGE, PHARMACEUTICAL, COSMETICS and PERSONAL CARE, NUTRACEUTICAL): Global Opportunity Analysis and Industry Forecast, 2021-2031

Description

List of Tables

The caffeine market size was $715.2 million in 2021 and is estimated to reach $ 1,194 million by 2031, registering a CAGR of 5.2% from 2022 to 2031. Caffeine is an alkaloid compound that is found especially in coffee, guarana, tea, cocoa, guayusa, yaupon holly, and other plants and is a stimulant of the central nervous system as well as acts as a psychoactive drug. Caffeine is a white crystalline purine, mostly a methylxanthine alkaloid with a bitter taste. There are two types of caffeine available in the market such as natural and synthesized caffeine, which are derived from natural and synthetic sources. Commercially natural caffeine is obtained from decaffeinated coffee and tea by extraction using a solvent. Synthetic caffeine is produced from synthetic sources such as urea and chloroacetic acid.

Energy drink manufacturers such as Red bull Inc., Monster Beverages Corporation, The Coca-Cola Company, and others use aggressive marketing campaigns to capture the major share. They majorly target adventurous sports and events such as snowboarding, motorbike sports, and water sports. This creates awareness among consumers and viewers about the energy drink and its health benefits. In addition, these players are launching products with various flavors and tastes to attract a huge customer base, thus the increasing penetration of the sports nutrition industry is expected to create more opportunities for key players in the caffeine market in the upcoming years.

Excessive caffeine consumption has undesirable side effects, including anxiety, sleeplessness, headaches, nausea, and dizziness. Consumers opted out of healthier caffeinated alternatives as a result of these adverse consequences. There is different caffeine substitutes are available in the market such as ginseng, pomegranate juice, maca, baobab, reishi, and others. According to the FDA, 400 mg of caffeine per day, or about 4 or 5 cups of coffee, is usually not harmful or dangerous for healthy adults, but exceeding this limit can have adverse effects. Furthermore, the key players in the food & beverages industry are focusing on research and development to produce an innovative ingredient that may replace caffeine in food & beverage products. excessive consumption of caffeine can cause adverse health effects, which are expected to hinder the growth of the caffeine market.

According to the market analysis, the global caffeine market is segmented into type, application, and region. Based on type, the market is divided into synthesized caffeine and natural caffeine. By application, the market is divided into food, beverages, pharmaceutical, cosmetics and personal care, and nutraceutical. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, Italy, Spain, UK, Russia, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, Indonesia, Thailand, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, UAE, Argentina, and rest of LAMEA).

By type, the market is bifurcated into synthesized caffeine and natural caffeine. The synthetic caffeine segment constitutes a major caffeine market share. This is attributed to increase in the demand for synthetic caffeine has increased owing to the increase in population. Overproduction of caffeine helps to lower the cost; the dependency of various industries on caffeine has increased extensively. Caffeine is one of the major ingredients used in energy drinks, cola, and other caffeinated beverages. Synthetic caffeine is widely used in the pharmaceutical and nutraceutical industry as ingredient. Especially in Asia-Pacific, the demand for synthetic caffeine is anticipated to increase during the forecast period, owing to its high purchasing power.

By application, the pharmaceutical segment dominated the global market and is expected to retain its dominance during the caffeine market forecast period. Majority of the caffeine is utilized in the pharmaceutical industry. Rise in awareness regarding health benefits associated with caffeine consumption is expected to propel the growth of the caffeine market. The caffeine market in LAMEA is anticipated to grow with a CAGR of 6.4% between 2022 and 2031, while the Asia-Pacific market is anticipated to witness a CAGR of 5.8%.

By region, Europe region dominated the global market and is expected to retain its dominance during the caffeine market forecast period. Germany is the leading market in Europe and is also expected to be the fastest growing market. The consumption of caffeine by end-user industries is increasing at a significant rate in Europe, owing to a rise in awareness regarding the health benefits of caffeine among consumers. Europe operates as a single market with 28 countries and is tagged as the major trading power. Furthermore, an increase in product diversification in the category of food & beverages and the development of natural caffeine is expected to propel the demand for caffeine in the upcoming years.

The impact of the COVID-19 outbreak was moderate for the growth of the global caffeine market. The trade restrictions and lockdown resulted in the halting of production and manufacturing units. The recovery of the caffeine market is expected in near future.
The players in the caffeine market have adopted acquisition, business expansion, partnership, collaboration, and product launch as their key development strategies to increase profitability and improve their position in the caffeine market. Some of the key players profiled in the caffeine market analysis Aarti Industries Limited, BASF SE, Caesar & Loretz GmbH, CSPC Pharmaceutical Group Limited., Jilin Province Synthetic Pharmaceutical Co., Ltd., JoinTown Pharmaceutical Group Co., Ltd., Ravago Group, Shandong Xinhua Pharmaceutical Co., Ltd., Spectrum Laboratory Products, Inc., and Taj Pharma Group
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the caffeine market analysis from 2021 to 2031 to identify the prevailing caffeine market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the caffeine market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global caffeine market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By APPLICATION

FOOD
BEVERAGE
PHARMACEUTICAL
COSMETICS and PERSONAL CARE
NUTRACEUTICAL

By TYPE

SYNTHESIZED CAFFEINE
NATURAL CAFFEINE

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- Italy
- Spain
- UK
- Russia
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Indonesia
- Thailand
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Saudi Arabia
- UAE
- Argentina
- Rest of LAMEA
Key Market Players
- JoinTown Pharmaceutical Group Co., Ltd.
- Spectrum Laboratory Products, Inc.
- Taj Pharma Group
- CSPC Pharmaceutical Group Limited.
- Caesar & Loretz GmbH
- Ravago Group
- Aarti Industries Limited
- BASF SE
- Shandong Xinhua Pharmaceutical Co., Ltd.
- Jilin Province Synthetic Pharmaceutical Co., Ltd.

Product Code: A03111

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Market dynamics
- 3.4.1.Drivers
  - 3.4.1.1. Caffeine is Gaining Popularity in Nutraceuticals
  - 3.4.1.2. Surge in the functional beverages market in Asia-Pacific
  - 3.4.1.3. Rise in number of athletes and sports persons
- 3.4.2.Restraints
  - 3.4.2.1. The Detrimental Effects of Excessive Caffeine consumption
  - 3.4.2.2. Undefined regulatory guidelines
- 3.4.3.Opportunities
  - 3.4.3.1. Rise in consumer demand for allergen-free food & beverages
  - 3.4.3.2. Increase in penetration of the sports nutrition industry
3.5.COVID-19 Impact Analysis on the market

CHAPTER 4: CAFFEINE MARKET, BY TYPE

4.1 Overview
- 4.1.1 Market size and forecast
4.2 SYNTHESIZED CAFFEINE
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market share analysis by country
4.3 NATURAL CAFFEINE
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market share analysis by country

CHAPTER 5: CAFFEINE MARKET, BY APPLICATION

5.1 Overview
- 5.1.1 Market size and forecast
5.2 FOOD
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market share analysis by country
5.3 BEVERAGE
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market share analysis by country
5.4 PHARMACEUTICAL
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market share analysis by country
5.5 COSMETICS and PERSONAL CARE
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market share analysis by country
5.6 NUTRACEUTICAL
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market share analysis by country

CHAPTER 6: CAFFEINE MARKET, BY REGION

6.1 Overview
- 6.1.1 Market size and forecast
6.2 North America
- 6.2.1 Key trends and opportunities
- 6.2.2 North America Market size and forecast, by TYPE
- 6.2.3 North America Market size and forecast, by APPLICATION
- 6.2.4 North America Market size and forecast, by country
  - 6.2.4.1 U.S.
  - 6.2.4.1.1 Key market trends, growth factors and opportunities
  - 6.2.4.1.2 Market size and forecast, by TYPE
  - 6.2.4.1.3 Market size and forecast, by APPLICATION
  - 6.2.4.2 Canada
  - 6.2.4.2.1 Key market trends, growth factors and opportunities
  - 6.2.4.2.2 Market size and forecast, by TYPE
  - 6.2.4.2.3 Market size and forecast, by APPLICATION
  - 6.2.4.3 Mexico
  - 6.2.4.3.1 Key market trends, growth factors and opportunities
  - 6.2.4.3.2 Market size and forecast, by TYPE
  - 6.2.4.3.3 Market size and forecast, by APPLICATION
6.3 Europe
- 6.3.1 Key trends and opportunities
- 6.3.2 Europe Market size and forecast, by TYPE
- 6.3.3 Europe Market size and forecast, by APPLICATION
- 6.3.4 Europe Market size and forecast, by country
  - 6.3.4.1 Germany
  - 6.3.4.1.1 Key market trends, growth factors and opportunities
  - 6.3.4.1.2 Market size and forecast, by TYPE
  - 6.3.4.1.3 Market size and forecast, by APPLICATION
  - 6.3.4.2 France
  - 6.3.4.2.1 Key market trends, growth factors and opportunities
  - 6.3.4.2.2 Market size and forecast, by TYPE
  - 6.3.4.2.3 Market size and forecast, by APPLICATION
  - 6.3.4.3 Italy
  - 6.3.4.3.1 Key market trends, growth factors and opportunities
  - 6.3.4.3.2 Market size and forecast, by TYPE
  - 6.3.4.3.3 Market size and forecast, by APPLICATION
  - 6.3.4.4 Spain
  - 6.3.4.4.1 Key market trends, growth factors and opportunities
  - 6.3.4.4.2 Market size and forecast, by TYPE
  - 6.3.4.4.3 Market size and forecast, by APPLICATION
  - 6.3.4.5 UK
  - 6.3.4.5.1 Key market trends, growth factors and opportunities
  - 6.3.4.5.2 Market size and forecast, by TYPE
  - 6.3.4.5.3 Market size and forecast, by APPLICATION
  - 6.3.4.6 Russia
  - 6.3.4.6.1 Key market trends, growth factors and opportunities
  - 6.3.4.6.2 Market size and forecast, by TYPE
  - 6.3.4.6.3 Market size and forecast, by APPLICATION
  - 6.3.4.7 Rest of Europe
  - 6.3.4.7.1 Key market trends, growth factors and opportunities
  - 6.3.4.7.2 Market size and forecast, by TYPE
  - 6.3.4.7.3 Market size and forecast, by APPLICATION
6.4 Asia-Pacific
- 6.4.1 Key trends and opportunities
- 6.4.2 Asia-Pacific Market size and forecast, by TYPE
- 6.4.3 Asia-Pacific Market size and forecast, by APPLICATION
- 6.4.4 Asia-Pacific Market size and forecast, by country
  - 6.4.4.1 China
  - 6.4.4.1.1 Key market trends, growth factors and opportunities
  - 6.4.4.1.2 Market size and forecast, by TYPE
  - 6.4.4.1.3 Market size and forecast, by APPLICATION
  - 6.4.4.2 Japan
  - 6.4.4.2.1 Key market trends, growth factors and opportunities
  - 6.4.4.2.2 Market size and forecast, by TYPE
  - 6.4.4.2.3 Market size and forecast, by APPLICATION
  - 6.4.4.3 India
  - 6.4.4.3.1 Key market trends, growth factors and opportunities
  - 6.4.4.3.2 Market size and forecast, by TYPE
  - 6.4.4.3.3 Market size and forecast, by APPLICATION
  - 6.4.4.4 Australia
  - 6.4.4.4.1 Key market trends, growth factors and opportunities
  - 6.4.4.4.2 Market size and forecast, by TYPE
  - 6.4.4.4.3 Market size and forecast, by APPLICATION
  - 6.4.4.5 South Korea
  - 6.4.4.5.1 Key market trends, growth factors and opportunities
  - 6.4.4.5.2 Market size and forecast, by TYPE
  - 6.4.4.5.3 Market size and forecast, by APPLICATION
  - 6.4.4.6 Indonesia
  - 6.4.4.6.1 Key market trends, growth factors and opportunities
  - 6.4.4.6.2 Market size and forecast, by TYPE
  - 6.4.4.6.3 Market size and forecast, by APPLICATION
  - 6.4.4.7 Thailand
  - 6.4.4.7.1 Key market trends, growth factors and opportunities
  - 6.4.4.7.2 Market size and forecast, by TYPE
  - 6.4.4.7.3 Market size and forecast, by APPLICATION
  - 6.4.4.8 Rest of Asia-Pacific
  - 6.4.4.8.1 Key market trends, growth factors and opportunities
  - 6.4.4.8.2 Market size and forecast, by TYPE
  - 6.4.4.8.3 Market size and forecast, by APPLICATION
6.5 LAMEA
- 6.5.1 Key trends and opportunities
- 6.5.2 LAMEA Market size and forecast, by TYPE
- 6.5.3 LAMEA Market size and forecast, by APPLICATION
- 6.5.4 LAMEA Market size and forecast, by country
  - 6.5.4.1 Brazil
  - 6.5.4.1.1 Key market trends, growth factors and opportunities
  - 6.5.4.1.2 Market size and forecast, by TYPE
  - 6.5.4.1.3 Market size and forecast, by APPLICATION
  - 6.5.4.2 South Africa
  - 6.5.4.2.1 Key market trends, growth factors and opportunities
  - 6.5.4.2.2 Market size and forecast, by TYPE
  - 6.5.4.2.3 Market size and forecast, by APPLICATION
  - 6.5.4.3 Saudi Arabia
  - 6.5.4.3.1 Key market trends, growth factors and opportunities
  - 6.5.4.3.2 Market size and forecast, by TYPE
  - 6.5.4.3.3 Market size and forecast, by APPLICATION
  - 6.5.4.4 UAE
  - 6.5.4.4.1 Key market trends, growth factors and opportunities
  - 6.5.4.4.2 Market size and forecast, by TYPE
  - 6.5.4.4.3 Market size and forecast, by APPLICATION
  - 6.5.4.5 Argentina
  - 6.5.4.5.1 Key market trends, growth factors and opportunities
  - 6.5.4.5.2 Market size and forecast, by TYPE
  - 6.5.4.5.3 Market size and forecast, by APPLICATION
  - 6.5.4.6 Rest of LAMEA
  - 6.5.4.6.1 Key market trends, growth factors and opportunities
  - 6.5.4.6.2 Market size and forecast, by TYPE
  - 6.5.4.6.3 Market size and forecast, by APPLICATION

CHAPTER 7: COMPANY LANDSCAPE

7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.5. Top player positioning, 2021

CHAPTER 8: COMPANY PROFILES

8.1 JoinTown Pharmaceutical Group Co., Ltd.
- 8.1.1 Company overview
- 8.1.2 Key Executives
- 8.1.3 Company snapshot
- 8.1.4 Operating business segments
- 8.1.5 Product portfolio
- 8.1.6 Business performance
- 8.1.7 Key strategic moves and developments
8.2 Spectrum Laboratory Products, Inc.
- 8.2.1 Company overview
- 8.2.2 Key Executives
- 8.2.3 Company snapshot
- 8.2.4 Operating business segments
- 8.2.5 Product portfolio
- 8.2.6 Business performance
- 8.2.7 Key strategic moves and developments
8.3 Taj Pharma Group
- 8.3.1 Company overview
- 8.3.2 Key Executives
- 8.3.3 Company snapshot
- 8.3.4 Operating business segments
- 8.3.5 Product portfolio
- 8.3.6 Business performance
- 8.3.7 Key strategic moves and developments
8.4 CSPC Pharmaceutical Group Limited.
- 8.4.1 Company overview
- 8.4.2 Key Executives
- 8.4.3 Company snapshot
- 8.4.4 Operating business segments
- 8.4.5 Product portfolio
- 8.4.6 Business performance
- 8.4.7 Key strategic moves and developments
8.5 Caesar & Loretz GmbH
- 8.5.1 Company overview
- 8.5.2 Key Executives
- 8.5.3 Company snapshot
- 8.5.4 Operating business segments
- 8.5.5 Product portfolio
- 8.5.6 Business performance
- 8.5.7 Key strategic moves and developments
8.6 Ravago Group
- 8.6.1 Company overview
- 8.6.2 Key Executives
- 8.6.3 Company snapshot
- 8.6.4 Operating business segments
- 8.6.5 Product portfolio
- 8.6.6 Business performance
- 8.6.7 Key strategic moves and developments
8.7 Aarti Industries Limited
- 8.7.1 Company overview
- 8.7.2 Key Executives
- 8.7.3 Company snapshot
- 8.7.4 Operating business segments
- 8.7.5 Product portfolio
- 8.7.6 Business performance
- 8.7.7 Key strategic moves and developments
8.8 BASF SE
- 8.8.1 Company overview
- 8.8.2 Key Executives
- 8.8.3 Company snapshot
- 8.8.4 Operating business segments
- 8.8.5 Product portfolio
- 8.8.6 Business performance
- 8.8.7 Key strategic moves and developments
8.9 Shandong Xinhua Pharmaceutical Co., Ltd.
- 8.9.1 Company overview
- 8.9.2 Key Executives
- 8.9.3 Company snapshot
- 8.9.4 Operating business segments
- 8.9.5 Product portfolio
- 8.9.6 Business performance
- 8.9.7 Key strategic moves and developments
8.10 Jilin Province Synthetic Pharmaceutical Co., Ltd.
- 8.10.1 Company overview
- 8.10.2 Key Executives
- 8.10.3 Company snapshot
- 8.10.4 Operating business segments
- 8.10.5 Product portfolio
- 8.10.6 Business performance
- 8.10.7 Key strategic moves and developments